Author

C. Snell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:protein sequence· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

M. Gough· 2 shared B. L. de la Pena Avalos· 1 shared E. Dray· 1 shared J. Gunter· 1 shared J. Hooper· 1 shared P. H. G. Duijf· 1 shared R. Tropee· 1 shared T. Khan· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. Gough

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Glycogen phosphorylase inhibition alongside taxol chemotherapy synergistically elicits ferroptotic cell death in clear cell ovarian and kidney cancers

T. Khan, Y. He, T. Kryza, J. Gunter, M. Gough, C. Snell, J. Hooper

The paper shows that inhibiting glycogen phosphorylase with CP91149 synergizes with taxol to induce ferroptotic cell death in clear cell ovarian and kidney cancers.

bioRxiv · May 1, 2023 · PreprintCancer Biology

The chromatin remodeler SMARCD3 regulates cell cycle progression and its expression predicts survival outcome in ER+ breast cancer

R. Tropee, B. L. de la Pena Avalos, M. Gough, C. Snell, P. H. G. Duijf, E. Dray

This paper shows SMARCD3 expression correlates with survival in ER+ breast cancer and regulates cell cycle progression, suggesting it as a prognostic biomarker and tumor suppressor.

bioRxiv · Jul 2, 2019 · PreprintCancer Biology